Next month, Aphria Inc. (APHA.TO) (APHA) will hold a special shareholder meeting to vote on the previously announced merger with Tilray, Inc. (TLRY).
This has been a hot topic of discussion and the market has responded favorably to the potential mega-merger. We believe the combined company will have an attractive portfolio of international cannabis assets and expect it to have a larger market share of Canada’s medical and recreational industry, once the deal is complete.
Another topic that we have been asked about the transaction is related to what Canadian Aphria shareholders will receive as part of the agreement. Since Tilray will be the surviving entity of the merger, its symbol will not change when the merger is completed.
Tilray is not like every other Canadian Licensed Producer (LP) and is the only one to trade exclusively on the Nasdaq. When compared to companies like Canopy Growth Corporation (WEED.TO) (CGC) or Aurora Cannabis Inc. (ACB.TO) (ACB), which trade in both Canada and the US, Tilray only has a US symbol.
We believe that the landscape of the legal cannabis industry is changing rapidly and the structure of the Aphria-Tilray merger to highlight how much the industry has evolved. Going forward, we expect to see an increased focus on the US market from Canadian LPs and expect operators to follow a strategy that is similar to Tilray.
In regards to the Tilray-Aphria merger, we expect Tilray to have a Canadian symbol on the Toronto Stock Exchange (TSX) before the transaction is completed. We are bullish on the growth prospects that are associated with the Tilray-Aphria merger agreement and believe that our readers need to be aware of the opportunity.
If you are interested in learning more about the Aphria-Tilray merger, please send an email to firstname.lastname@example.org with the subject “Aphria-Tilray Merger” to be added to our distribution list.